{"title":"Progressive leptomeningeal involvement on gadolinium-enhanced FLAIR MRI in hereditary transthyretin amyloidosis with the V30M (p.V50M) mutation.","authors":"Yohei Misumi, Toshiya Nomura, Tomoaki Taguchi, Shiori Yamakawa, Hiroyuki Uetani, Masayoshi Tasaki, Konen Obayashi, Taro Yamashita, Toshinori Hirai, Yukio Ando, Mitsuharu Ueda","doi":"10.1080/13506129.2026.2702928","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Advances in disease-modifying therapies for hereditary transthyretin (ATTRv) amyloidosis have improved long-term survival. As a result, central nervous system (CNS) involvement, particularly leptomeningeal amyloidosis and cerebral amyloid angiopathy, is increasingly encountered in V30M (p.V50M) patients. However, the frequency, distribution, and progression of CNS involvement on MRI remain unclear.</p><p><strong>Methods: </strong>We retrospectively analyzed patients with ATTR V30M amyloidosis who underwent brain MRI with gadolinium-enhanced FLAIR (Gd-FLAIR) or susceptibility-weighted imaging (SWI) between 2010 and 2025. Associations between leptomeningeal enhancement, cerebral microbleeds, and clinical parameters were evaluated.</p><p><strong>Results: </strong>Leptomeningeal enhancement on Gd-FLAIR was observed in 13/44 patients (29.5%); disease duration was longer in patients with enhancement than in those without (15.0 [8.9-22.8] vs. 5.2 [2.4-10.5] years, <i>p</i> < 0.001). The semiquantitative Gd-FLAIR score correlated with disease duration (<i>r<sub>s</sub></i> = 0.56, <i>p</i> < 0.001). In contrast, cerebral microbleeds were not associated with disease duration or progression. Leptomeningeal enhancement appeared as focal surface lesions in early stages and became diffuse in advanced stages, predominantly involving the posterior fossa.</p><p><strong>Conclusions: </strong>Leptomeningeal enhancement on Gd-FLAIR MRI is a frequent and progressive finding associated with disease duration and may precede cerebral microbleeds, supporting its role as an early and sensitive marker in ATTR V30M amyloidosis.</p>","PeriodicalId":50964,"journal":{"name":"Amyloid-Journal of Protein Folding Disorders","volume":" ","pages":"1-9"},"PeriodicalIF":5.1000,"publicationDate":"2026-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Amyloid-Journal of Protein Folding Disorders","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/13506129.2026.2702928","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Advances in disease-modifying therapies for hereditary transthyretin (ATTRv) amyloidosis have improved long-term survival. As a result, central nervous system (CNS) involvement, particularly leptomeningeal amyloidosis and cerebral amyloid angiopathy, is increasingly encountered in V30M (p.V50M) patients. However, the frequency, distribution, and progression of CNS involvement on MRI remain unclear.
Methods: We retrospectively analyzed patients with ATTR V30M amyloidosis who underwent brain MRI with gadolinium-enhanced FLAIR (Gd-FLAIR) or susceptibility-weighted imaging (SWI) between 2010 and 2025. Associations between leptomeningeal enhancement, cerebral microbleeds, and clinical parameters were evaluated.
Results: Leptomeningeal enhancement on Gd-FLAIR was observed in 13/44 patients (29.5%); disease duration was longer in patients with enhancement than in those without (15.0 [8.9-22.8] vs. 5.2 [2.4-10.5] years, p < 0.001). The semiquantitative Gd-FLAIR score correlated with disease duration (rs = 0.56, p < 0.001). In contrast, cerebral microbleeds were not associated with disease duration or progression. Leptomeningeal enhancement appeared as focal surface lesions in early stages and became diffuse in advanced stages, predominantly involving the posterior fossa.
Conclusions: Leptomeningeal enhancement on Gd-FLAIR MRI is a frequent and progressive finding associated with disease duration and may precede cerebral microbleeds, supporting its role as an early and sensitive marker in ATTR V30M amyloidosis.
期刊介绍:
Amyloid: the Journal of Protein Folding Disorders is dedicated to the study of all aspects of the protein groups and associated disorders that are classified as the amyloidoses as well as other disorders associated with abnormal protein folding. The journals major focus points are:
etiology,
pathogenesis,
histopathology,
chemical structure,
nature of fibrillogenesis;
whilst also publishing papers on the basic and chemical genetic aspects of many of these disorders.
Amyloid is recognised as one of the leading publications on amyloid protein classifications and the associated disorders, as well as clinical studies on all aspects of amyloid related neurodegenerative diseases and major clinical studies on inherited amyloidosis, especially those related to transthyretin. The Journal also publishes book reviews, meeting reports, editorials, thesis abstracts, review articles and symposia in the various areas listed above.